查看購物車
  • English
  • Japanese
  • Korean
全球製藥生產設備市場：按設備類型、最終產品和技術分類－預測（至2032年）
市場調查報告書
商品編碼
1963145

全球製藥生產設備市場：按設備類型、最終產品和技術分類－預測（至2032年）

Pharmaceutical Manufacturing Equipment Market by Equipment Type (Packaging, Filling, Spray Drying, Mixing & Blending, Milling, Tablet Compression, Inspection, Granulation, Sterilization), End Product (Solid, Liquid), Technology - Global Forecast to 2032
出版日期: | 出版商: MarketsandMarkets | 英文 322 Pages | 訂單完成後即時交付

價格

全球製藥生產設備市場預計到 2026 年將達到 212.4 億美元，到 2032 年將達到 303.9 億美元，預測期內複合年成長率為 6.2%。

由於對高效合規的藥品生產系統的需求不斷成長，市場正在穩步發展。製藥公司正在擴大產能，以滿足日益成長的藥品需求。

調查範圍
調查期 2021-2032
基準年 2024
預測期 2026-2032
單元 10億美元
部分 設備類型、技術、地區
目標區域 北美、歐洲、亞太地區及其他地區

加工精度和產品品質仍然是重中之重。監管合規要求正在推動生產線的現代化。對學名藥藥和生物製藥日益成長的需求支撐著可擴展的生產解決方案。嚴格的品質標準要求使用檢驗且可靠的設備。對製藥基礎設施的投資持續成長。這些因素正在推動全球製藥公司採用先進的生產設備。

製藥生產設備市場-IMG1

“預計從2026年到2032年，包裝機械領域的複合年成長率將最高。”

隨著人們對安全合規的藥品包裝日益關注，預計在預測期內，包裝機械將成為複合年成長率最高的行業。製藥公司優先考慮產品保護和延長保存期限。嚴格的監管要求推動了對先進包裝系統投資的增加。隨著片劑和膠囊產量的成長，包裝數量也在增加。注射劑也需要安全處理。防篡改包裝的需求日益成長。此外，旨在確保可追溯性和降低假冒風險的自動化和序列化技術的日益普及，進一步加速了製藥生產設施對先進包裝機械的需求。

“預計在預測期內，液體製劑領域將主導製藥生產設備市場。”

預計注射劑和生物製藥需求的成長將推動液體製劑在預測期內佔據最大的市場佔有率。對疫苗和口服液的需求也在推動產量成長。慢性病盛行率的上升促進了無菌製劑產量的成長。免疫接種計劃的擴展增強了各地區的需求。製藥公司正在投資先進的填充和密封系統。契約製造的成長提高了產能。患者對便捷給藥方式的偏好日益增強，推動了液體製劑的普及。這種轉變促使全球對液體製劑生產基礎設施的資本投資增加。

“到2025年，中國將佔據亞太地區製藥設備市場最大的佔有率。”

由於其大規模的生產能力，中國將在預測期內佔據全球製藥設備市場最大的佔有率。中國在原料藥（API）和學名藥的生產方面保持著強大的地位。其生產設施基礎廣泛，涵蓋了從小規模國內製造商到出口型企業的各種規模。許多工廠都運作了先進的自動化生產線。對生物製藥和疫苗的投資不斷成長，並推高了對設備的需求。無菌生產的擴張推動了國內製程系統的現代化。契約製造的成長進一步增加了產能，而為滿足國際監管標準而進行的設施現代化改造也增強了需求。這些合規要求正在推動檢驗系統的應用。這些因素使中國成為製藥設備的重要市場。

本報告對全球製藥生產設備市場進行了深入分析，深入探討了關鍵促進因素和限制因素、產品開發和創新以及競爭格局。

目錄

第1章：引言

第2章執行摘要

第3章 主要發現

  • 對於製藥設備市場的公司來說，這是一部極具吸引力的劇集。
  • 製藥生產設備市場：依設備類型分類
  • 製藥生產設備市場：依最終產品類型分類
  • 製藥生產設備市場：依技術分類
  • 北美製藥生產設備市場：按設備類型和國家分類
  • 製藥生產設備市場：按地區分類

第4章 市場概覽

  • 市場動態
    • 促進因素
    • 抑制因子
    • 機會
    • 任務
  • 相互關聯的市場與跨產業機遇
  • 一、二、三級企業的策略性舉措

第5章 產業趨勢

  • 波特五力分析
  • 宏觀經濟展望
    • GDP趨勢與預測
    • 全球生物製藥和疫苗製造業的趨勢
    • 全球學名藥和口服固體製劑生產產業的趨勢
  • 價值鏈分析
  • 生態系分析
  • 定價分析
    • 主要企業提供的製藥生產設備價格範圍：按設備類型分類（2025 年）
    • 包裝機械平均售價趨勢（2022-2025）
    • 包裝機械平均售價趨勢：依地區分類（2022-2025 年）
  • 投資和資金籌措場景
  • 貿易分析
    • 進口場景（HS編碼8479）
    • 出口方案（HS編碼8479）
  • 影響客戶業務的趨勢/干擾因素
  • 重大會議和活動（2026 年）
  • 案例研究分析
  • 2025年美國關稅的影響 - 製藥生產設備市場
    • 主要關稅稅率
    • 價格影響分析
    • 國家/地區
    • 對設備類型的影響

第6章：技術進步、人工智慧的影響、專利與創新

  • 主要技術
    • 永續製造
    • 數位雙胞胎
    • 滅菌和無菌處理
    • 固態劑型的生產
    • 自動化和機器人技術
    • 物聯網和智慧感測器
  • 鄰近技術
    • 電腦輔助設計（CAD）和電腦輔助製造（CAM）
    • 先進的CNC加工和精密製造
  • 互補技術
    • 3D列印
    • 工業自動化系統
  • 技術藍圖
  • 專利分析
  • 人工智慧對製藥生產設備市場的影響
    • 主要應用案例和市場展望
    • 製藥生產設備市場中OEM廠商的最佳實踐
    • 人工智慧在製藥製造設備市場案例研究
    • 相互關聯的生態系統及其對市場企業的影響
    • 客戶對採用人工智慧整合製藥生產設備的準備情況

第7章 監理情勢

  • 當地法規和合規性
    • 監管機構、政府機構和其他組織
    • 業界標準
    • 規章

第8章：顧客趨勢與購買行為

  • 決策流程
  • 參與採購流程和評估標準的關鍵相關利益者
    • 採購過程中的關鍵相關利益者
    • 購買標準
  • 招募障礙和內部挑戰
  • 設備類型的未滿足需求

第9章：製藥生產設備的最終用戶

  • 製藥公司
  • 製藥受託製造公司

第10章：藥品器材的製造程序

  • 配方過程
  • 片劑化和膠囊化工藝
  • 無菌工藝
  • 包裝過程
  • 品管過程

第11章 製藥生產設備市場：依設備類型分類

  • 包裝機
  • 灌裝機
  • 噴霧乾燥裝置
  • 混合器
  • 銑床
  • 擠出機
  • 平板電腦壓縮機
  • 檢測設備
  • 製粒設備
  • 消毒器

第12章 製藥生產設備市場：依最終產品類型分類

  • 固體的
  • 液體

第13章 製藥生產設備市場：依技術分類

  • 半自動
  • 自動的

第14章 製藥生產設備市場：依地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 其他亞太地區
  • 其他地區
    • 中東和非洲
    • 南美洲

第15章 競爭格局

  • 概述
  • 主要參與企業的策略/優勢（2022-2026 年）
  • 收入分析（2021-2025）
  • 市佔率分析（2025 年）
  • 企業評估與財務指標
  • 品牌對比
  • 企業評估矩陣：主要企業（2025 年）
  • 公司評估矩陣：Start-Ups/中小企業（2025 年）
  • 競爭格局

第16章：公司簡介

  • 主要企業
    • GEA GROUP AKTIENGESELLSCHAFT
    • KORBER AG
    • IMA INDUSTRIA MACCHINE AUTOMATICHE SPA
    • SYNTEGON TECHNOLOGY GMBH
    • ACG
    • THERMO FISHER SCIENTIFIC INC.
    • ROMACO GROUP
    • MARCHESINI GROUP SPA
    • MG2 SRL
    • GLATT GMBH
  • 其他公司
    • BAUSCH+STROBEL SE+CO. KG
    • COPERION GMBH
    • ELIZABETH COMPANIES
    • FETTE COMPACTING
    • FREUND
    • KORSCH AG
    • LB BOHLE MASCHINEN UND VERFAHREN GMBH
    • LFA MACHINES
    • CVC TECHNOLOGIES, INC.
    • OHARA TECHNOLOGIES
    • PRISM PHARMA MACHINERY
    • SAINTYCO
    • SILVERSON
    • YENCHEN MACHINERY CO., LTD.
    • QUALICAPS
    • COESIA SPA
    • UHLMANN
    • AST, LLC

第17章調查方法

第18章附錄

Product Code: SE 8645

The global pharmaceutical manufacturing equipment market size is projected to be USD 21.24 billion in 2026 and USD 30.39 billion by 2032, registering a CAGR of 6.2% during the forecast period. The market is progressing steadily due to the rising demand for efficient and compliant drug production systems. Pharmaceutical companies are expanding production capacity to meet growing medicine demand.

Scope of the Report
Years Considered for the Study2021-2032
Base Year2024
Forecast Period2026-2032
Units ConsideredValue (USD Billion)
SegmentsBy Equipment Type, Technology and Region
Regions coveredNorth America, Europe, APAC, RoW

Process accuracy and product quality remain key priorities. Regulatory compliance requirements drive the modernization of production lines. Increasing demand for generic drugs and biologics supports scalable manufacturing solutions. Strict quality standards require validated and reliable equipment. Investment in pharmaceutical infrastructure continues to rise. These factors support the adoption of advanced manufacturing equipment across global pharmaceutical facilities.

Pharmaceutical Manufacturing Equipment Market - IMG1

"Packaging machines segment is anticipated to grow at the fastest CAGR from 2026 to 2032"

Packing machines are expected to record the highest CAGR during the forecast period due to the growing emphasis on safe and compliant pharmaceutical packaging. Pharmaceutical companies are prioritizing product protection and shelf life extension. Strict regulatory requirements are increasing investment in advanced packaging systems. The growing production of tablets and capsules is raising packaging volumes. Injectable drugs also require secure handling. Demand for tamper-proof packaging is increasing. Additionally, the increasing adoption of automation and serialization technologies to ensure traceability and reduce counterfeiting risks is further accelerating the demand for advanced packaging machines across pharmaceutical manufacturing facilities.

"Liquid segment is expected to dominate the pharmaceutical manufacturing equipment market during the forecast period"

The liquid segment is expected to account for the largest market share during the forecast period due to the mounting demand for injectables and biologics. Vaccines and oral liquid medicines are also driving production growth. The increasing prevalence of chronic diseases supports the higher output of sterile formulations. Expansion of immunization programs strengthens demand across regions. Pharmaceutical companies are investing in advanced filling and sealing systems. Growth in contract manufacturing supports capacity expansion. Patient preference for easy administration is increasing the adoption of liquid forms. This shift supports higher capital investment in liquid manufacturing infrastructure globally.

"China held the largest share of the Asia Pacific pharmaceutical manufacturing equipment market in 2025"

China accounted for the largest share of the pharmaceutical manufacturing equipment market during the forecast period due to its large-scale production capacity. The country maintains a strong position in active pharmaceutical ingredient (API) and generic drug manufacturing. A wide base of facilities ranges from small domestic producers to export-focused companies. Many plants operate advanced automated production lines. Investment in biologics and vaccines is increasing equipment demand. Sterile manufacturing expansion supports process system upgrades in the country. Contract manufacturing growth drives additional capacity additions, while facility modernization to meet international regulatory standards strengthens demand. These compliance requirements encourage the adoption of validated systems. These factors position it as the leading market for pharmaceutical manufacturing equipment.

  • By Company Type: Tier 1 - 40%, Tier 2 - 35%, and Tier 3 - 25%
  • By Designation: Directors - 40%, C-level Executives - 45%, and Others - 15%
  • By Region: North America - 26%, Europe - 28%, Asia Pacific - 41%, and RoW - 5%

Prominent players profiled in this report include GEA Group Aktiengesellschaft (Germany), IMA Industria Macchine Automatiche S.p.A (Italy), Syntegon Technology GmbH (Germany), ACG (India), Thermo Fisher Scientific Inc (US), Korber AG (Germany), Coperion GmbH (Germany), Romaco Group (Germany), Marchesini Group S.p.A (Italy), and Bausch+Strobel SE + Co. KG (Germany).

Research Coverage

The report defines, describes, and forecasts the pharmaceutical manufacturing equipment market based on equipment type (packaging machines, filling machines, spray drying equipment, mixing & blending machines, milling equipment, extrusion equipment, tablet compression presses, inspection equipment, granulation equipment, and sterilization equipment), end-product type (solid and liquid), and technology (semi-automatic and automatic). It also analyzes the market across key regions, including North America, Europe, Asia Pacific, and RoW. The report provides detailed insights into the major drivers, restraints, opportunities, and challenges influencing market growth. In addition, it evaluates competitive developments, such as product launches, expansions, partnerships, acquisitions, and strategic initiatives undertaken by leading companies to strengthen their market position.

Reasons to Buy This Report

The report will help market leaders/new entrants with information on the closest approximations of the revenue for the overall pharmaceutical manufacturing equipment market and its subsegments. The report will help stakeholders understand the competitive landscape and gain more insight to position their business better and plan suitable go-to-market strategies. The report also helps stakeholders understand the market's pulse and provides information on key drivers, restraints, opportunities, and challenges.

The report will provide insights into the following points:

  • Analysis of Key Drivers (Increasing commercialization of biologics and complex formulations, Growing preference for personalized medicines and targeted therapies, Rapid advances in automation, digital monitoring, and Industry 4.0 technologies, Escalating generic drug production), restraints (High capital expenditure requirements, Issues related to integration with existing systems, Implementation of stringent regulatory compliance standards), opportunities (Expansion of contract development and manufacturing organizations, Mounting demand for sterile and aseptic injectable drugs, Rising integration of advanced inspection and serialization technologies), and challenges (Requirement for frequent technological upgrades, Complex validation and revalidation cycles, Technical and operational challenges related to small-batch production) of the pharmaceutical manufacturing equipment market.
  • Product Development/Innovation: Detailed insights into upcoming technologies, research & development activities, and product launches in the pharmaceutical manufacturing equipment market
  • Market Development: Comprehensive information about lucrative markets (the report analyzes the pharmaceutical manufacturing equipment market across various regions)
  • Market Diversification: Exhaustive information about new product launches, untapped geographies, recent developments, and investments in the pharmaceutical manufacturing equipment market
  • Competitive Assessment: In-depth assessment of market share, growth strategies, and offering of leading players, including GEA Group Aktiengesellschaft (Germany), IMA Industria Macchine Automatiche S.p.A (Italy), Syntegon Technology GmbH (Germany), ACG (India), and Thermo Fisher Scientific Inc (US) in the pharmaceutical manufacturing equipment market

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE
    • 1.3.2 YEARS CONSIDERED
    • 1.3.3 INCLUSIONS AND EXCLUSIONS
  • 1.4 CURRENCY CONSIDERED
  • 1.5 UNIT CONSIDERED
  • 1.6 LIMITATIONS
  • 1.7 STAKEHOLDERS
  • 1.8 SUMMARY OF CHANGES

2 EXECUTIVE SUMMARY

  • 2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS
  • 2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS
  • 2.3 DISRUPTIVE TRENDS IN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET
  • 2.4 HIGH-GROWTH SEGMENTS
  • 2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST

3 PREMIUM INSIGHTS

  • 3.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET
  • 3.2 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE
  • 3.3 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE
  • 3.4 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY TECHNOLOGY
  • 3.5 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY EQUIPMENT TYPE AND COUNTRY
  • 3.6 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY GEOGRAPHY

4 MARKET OVERVIEW

  • 4.1 INTRODUCTION
  • 4.2 MARKET DYNAMICS
    • 4.2.1 DRIVERS
      • 4.2.1.1 Increasing commercialization of biologics and complex formulations
      • 4.2.1.2 Growing preference for personalized medicines and targeted therapies
      • 4.2.1.3 Rapid advances in automation, digital monitoring, and Industry 4.0 technologies
      • 4.2.1.4 Escalating generic drug production
    • 4.2.2 RESTRAINTS
      • 4.2.2.1 High capital expenditure requirements
      • 4.2.2.2 Issues related to integration with existing systems
      • 4.2.2.3 Implementation of stringent regulatory compliance standards
    • 4.2.3 OPPORTUNITIES
      • 4.2.3.1 Expansion of contract development and manufacturing organizations
      • 4.2.3.2 Mounting demand for sterile and aseptic injectable drugs
      • 4.2.3.3 Rising deployment of advanced inspection and serialization technologies
    • 4.2.4 CHALLENGES
      • 4.2.4.1 Requirement for frequent technological upgrades
      • 4.2.4.2 Complex validation and revalidation cycles
      • 4.2.4.3 Technical and operational challenges related to small-batch production
  • 4.3 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
  • 4.4 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS

5 INDUSTRY TRENDS

  • 5.1 PORTER'S FIVE FORCES ANALYSIS
    • 5.1.1 BARGAINING POWER OF SUPPLIERS
    • 5.1.2 BARGAINING POWER OF BUYERS
    • 5.1.3 THREAT OF NEW ENTRANTS
    • 5.1.4 THREAT OF SUBSTITUTES
    • 5.1.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.2 MACROECONOMIC OUTLOOK
    • 5.2.1 INTRODUCTION
    • 5.2.2 GDP TRENDS AND FORECAST
    • 5.2.3 TRENDS IN GLOBAL BIOPHARMACEUTICAL & VACCINE MANUFACTURING INDUSTRY
    • 5.2.4 TRENDS IN GLOBAL GENERIC DRUG & ORAL SOLID DOSAGE MANUFACTURING INDUSTRY
  • 5.3 VALUE CHAIN ANALYSIS
  • 5.4 ECOSYSTEM ANALYSIS
  • 5.5 PRICING ANALYSIS
    • 5.5.1 PRICING RANGE OF PHARMACEUTICAL MANUFACTURING EQUIPMENT OFFERED BY KEY PLAYERS, BY EQUIPMENT TYPE, 2025
    • 5.5.2 AVERAGE SELLING PRICE TREND OF PACKAGING MACHINES, 2022-2025
    • 5.5.3 AVERAGE SELLING PRICE TREND OF PACKAGING MACHINES, BY REGION, 2022-2025
  • 5.6 INVESTMENT AND FUNDING SCENARIO
  • 5.7 TRADE ANALYSIS
    • 5.7.1 IMPORT SCENARIO (HS CODE 8479)
    • 5.7.2 EXPORT SCENARIO (HS CODE 8479)
  • 5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • 5.9 KEY CONFERENCES AND EVENTS, 2026
  • 5.10 CASE STUDY ANALYSIS
    • 5.10.1 INOXPA STRENGTHENS AVVA PHARMACEUTICALS' MANUFACTURING CAPABILITIES THROUGH MODULAR PHARMACEUTICAL PROCESSING SYSTEM
    • 5.10.2 GEA GROUP INSTALLS PSD-3 PHARMACEUTICAL SPRAY DRYER AT CHUGAI PHARMACEUTICAL'S FJ3 FACILITY TO PROCESS PHARMACEUTICAL COMPOUNDS
    • 5.10.3 ZAMBON COMPANY AND IMA ACTIVE COLLABORATE ON PROCESS OPTIMIZATION PROJECT TO ENHANCE BATCH CONSISTENCY AND QUALITY
    • 5.10.4 ACG HELPS INDIAN PHARMACEUTICAL COMPANY RETROFIT B MAX MACHINE WITH NITROGEN-ENHANCED PURGING SYSTEM TO IMPROVE STABILITY AND SHELF LIFE
    • 5.10.5 SYNTEGON PROVIDES AIM 5022S PLATFORM TO JIANGSU JINDIKE PHARMACEUTICAL TO ENHANCE INSPECTION EFFICIENCY AND ACCURACY
  • 5.11 IMPACT OF 2025 US TARIFF - PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET
    • 5.11.1 INTRODUCTION
    • 5.11.2 KEY TARIFF RATES
    • 5.11.3 PRICE IMPACT ANALYSIS
    • 5.11.4 IMPACT ON COUNTRIES/REGIONS
      • 5.11.4.1 US
      • 5.11.4.2 Europe
      • 5.11.4.3 Asia Pacific
    • 5.11.5 IMPACT ON EQUIPMENT TYPES

6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACTS, PATENTS, AND INNOVATIONS

  • 6.1 KEY TECHNOLOGIES
    • 6.1.1 CONTINUOUS MANUFACTURING
    • 6.1.2 DIGITAL TWIN
    • 6.1.3 STERILE AND ASEPTIC PROCESSING
    • 6.1.4 SOLID DOSAGE MANUFACTURING
    • 6.1.5 AUTOMATION AND ROBOTICS
    • 6.1.6 INTERNET OF THINGS (IOT) AND SMART SENSORS
  • 6.2 ADJACENT TECHNOLOGIES
    • 6.2.1 COMPUTER-AIDED DESIGN (CAD) AND COMPUTER-AIDED MANUFACTURING (CAM)
    • 6.2.2 ADVANCED CNC MACHINING AND PRECISION MANUFACTURING
  • 6.3 COMPLEMENTARY TECHNOLOGIES
    • 6.3.1 3D PRINTING
    • 6.3.2 INDUSTRIAL AUTOMATION SYSTEMS
  • 6.4 TECHNOLOGY ROADMAP
  • 6.5 PATENT ANALYSIS
  • 6.6 IMPACT OF AI ON PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET
    • 6.6.1 TOP USE CASES AND MARKET POTENTIAL
    • 6.6.2 BEST PRACTICES FOLLOWED BY OEMS IN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET
    • 6.6.3 CASE STUDIES RELATED TO AI IMPLEMENTATION IN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET
    • 6.6.4 INTERCONNECTED ECOSYSTEM AND IMPACT ON MARKET PLAYERS
    • 6.6.5 CLIENTS' READINESS TO ADOPT AI-INTEGRATED PHARMACEUTICAL MANUFACTURING EQUIPMENT

7 REGULATORY LANDSCAPE

  • 7.1 REGIONAL REGULATIONS AND COMPLIANCE
    • 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 7.1.2 INDUSTRY STANDARDS
    • 7.1.3 REGULATIONS

8 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR

  • 8.1 DECISION-MAKING PROCESS
  • 8.2 KEY STAKEHOLDERS INVOLVED IN BUYING PROCESS AND EVALUATION CRITERIA
    • 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 8.2.2 BUYING CRITERIA
  • 8.3 ADOPTION BARRIERS AND INTERNAL CHALLENGES
  • 8.4 UNMET NEEDS OF EQUIPMENT TYPES

9 END USERS OF PHARMACEUTICAL MANUFACTURING EQUIPMENT

  • 9.1 INTRODUCTION
  • 9.2 PHARMACEUTICAL MANUFACTURING COMPANIES
  • 9.3 CONTRACT MANUFACTURING ORGANIZATIONS

10 MANUFACTURING PROCESSES OF PHARMACEUTICAL EQUIPMENT

  • 10.1 INTRODUCTION
  • 10.2 FORMULATION PROCESS
  • 10.3 TABLETING & ENCAPSULATION PROCESS
  • 10.4 ASEPTIC PROCESS
  • 10.5 PACKAGING PROCESS
  • 10.6 QUALITY CONTROL PROCESS

11 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE

  • 11.1 INTRODUCTION
  • 11.2 PACKAGING MACHINES
    • 11.2.1 INCREASING PRODUCT AND STOCK KEEPING UNIT PROLIFERATION TO BOOST SEGMENTAL GROWTH
  • 11.3 FILLING MACHINES
    • 11.3.1 RISING STERILE AND ASEPTIC MANUFACTURING TO CONTRIBUTE TO SEGMENTAL GROWTH
  • 11.4 SPRAY DRYING EQUIPMENT
    • 11.4.1 ESCALATING NUMBER OF POORLY SOLUBLE DRUG MOLECULES TO FOSTER SEGMENTAL GROWTH
  • 11.5 MIXING & BLENDING MACHINES
    • 11.5.1 MOUNTING CONSUMPTION OF SOLID ORAL DOSAGE FORMS TO BOLSTER SEGMENTAL GROWTH
  • 11.6 MILLING EQUIPMENT
    • 11.6.1 RISING NEED FOR TIGHT PARTICLE SIZE CONTROL TO ACCELERATE SEGMENTAL GROWTH
  • 11.7 EXTRUSION EQUIPMENT
    • 11.7.1 GROWING EMPHASIS ON IMPROVING BIOAVAILABILITY OF POORLY SOLUBLE DRUGS TO SPUR DEMAND
  • 11.8 TABLET COMPRESSION PRESSES
    • 11.8.1 LARGE-SCALE PRODUCTION OF TABLETS AND HIGH-VOLUME PRODUCTION REQUIREMENTS TO FUEL SEGMENTAL GROWTH
  • 11.9 INSPECTION EQUIPMENT
    • 11.9.1 HEIGHTENED FOCUS ON QUALITY ASSURANCE AND RISK REDUCTION TO EXPEDITE SEGMENTAL GROWTH
  • 11.10 GRANULATION EQUIPMENT
    • 11.10.1 REQUIREMENT FOR CONSISTENT AND REPRODUCIBLE MANUFACTURING PROCESSES TO BOOST SEGMENTAL GROWTH
  • 11.11 STERILIZATION EQUIPMENT
    • 11.11.1 INCREASING PRODUCTION OF STERILE DRUGS AND REGULATORY SCRUTINY TO FOSTER SEGMENTAL GROWTH

12 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE

  • 12.1 INTRODUCTION
  • 12.2 SOLID
    • 12.2.1 STABILITY, EASE OF STORAGE AND TRANSPORT, AND LOW MANUFACTURING COSTS TO AUGMENT SEGMENTAL GROWTH
  • 12.3 LIQUID
    • 12.3.1 HIGH PREFERENCE FOR BIOLOGICS, VACCINES, AND INJECTABLE THERAPIES TO EXPEDITE SEGMENTAL GROWTH

13 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY TECHNOLOGY

  • 13.1 INTRODUCTION
  • 13.2 SEMI-AUTOMATIC
    • 13.2.1 MOUNTING DEMAND FOR SMALL-SCALE AND FLEXIBLE PHARMACEUTICAL MANUFACTURING TO FUEL SEGMENTAL GROWTH
  • 13.3 AUTOMATIC
    • 13.3.1 RISING NEED FOR HIGH PRODUCTIVITY AND STRINGENT REGULATORY REQUIREMENTS TO AUGMENT SEGMENTAL GROWTH

14 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION

  • 14.1 INTRODUCTION
  • 14.2 NORTH AMERICA
    • 14.2.1 US
      • 14.2.1.1 Increasing investment in compliance-ready equipment to strengthen healthcare production capabilities to drive market
    • 14.2.2 CANADA
      • 14.2.2.1 Mounting adoption of automation and regulatory frameworks to foster market growth
    • 14.2.3 MEXICO
      • 14.2.3.1 Rising domestic track-and-trace requirements and export compliance to support market growth
  • 14.3 EUROPE
    • 14.3.1 UK
      • 14.3.1.1 Government support for life sciences sector and strong regulatory standards to boost market growth
    • 14.3.2 GERMANY
      • 14.3.2.1 Strong engineering capabilities, advanced automation, and early adoption of digital manufacturing practices to drive market
    • 14.3.3 FRANCE
      • 14.3.3.1 High investment in validated manufacturing, filling, inspection, and packaging equipment to fuel market growth
    • 14.3.4 ITALY
      • 14.3.4.1 Growing focus on sterile and high-value manufacturing to contribute to market growth
    • 14.3.5 REST OF EUROPE
  • 14.4 ASIA PACIFIC
    • 14.4.1 CHINA
      • 14.4.1.1 Rising emphasis on innovative drug development and automated manufacturing technologies to expedite market growth
    • 14.4.2 JAPAN
      • 14.4.2.1 Strong focus on manufacturing process control, accuracy, and reliability to accelerate market growth
    • 14.4.3 INDIA
      • 14.4.3.1 Large-scale generic drug manufacturing base to drive market
    • 14.4.4 SOUTH KOREA
      • 14.4.4.1 Advanced technological capabilities and strong regulatory framework to foster market growth
    • 14.4.5 REST OF ASIA PACIFIC
  • 14.5 ROW
    • 14.5.1 MIDDLE EAST & AFRICA
      • 14.5.1.1 GCC
        • 14.5.1.1.1 Rising adoption of healthcare localization and economic diversification strategies to bolster market growth
      • 14.5.1.2 South Africa
        • 14.5.1.2.1 Increasing vaccine and biologics manufacturing capabilities to augment market growth
      • 14.5.1.3 Rest of Middle East & Africa
    • 14.5.2 SOUTH AMERICA
      • 14.5.2.1 Brazil
        • 14.5.2.1.1 Strong focus on compliance with track-and-trace regulations to contribute to market growth
      • 14.5.2.2 Argentina
        • 14.5.2.2.1 Mounting demand for tablet compression, capsule filling, granulation, and coating equipment to support market growth
      • 14.5.2.3 Rest of South America

15 COMPETITIVE LANDSCAPE

  • 15.1 OVERVIEW
  • 15.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2022-2026
  • 15.3 REVENUE ANALYSIS, 2021-2025
  • 15.4 MARKET SHARE ANALYSIS, 2O25
  • 15.5 COMPANY VALUATION AND FINANCIAL METRICS
  • 15.6 BRAND COMPARISON
  • 15.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
    • 15.7.1 STARS
    • 15.7.2 EMERGING LEADERS
    • 15.7.3 PERVASIVE PLAYERS
    • 15.7.4 PARTICIPANTS
    • 15.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
      • 15.7.5.1 Company footprint
      • 15.7.5.2 Region footprint
      • 15.7.5.3 Equipment type footprint
      • 15.7.5.4 End-product type footprint
      • 15.7.5.5 Technology footprint
  • 15.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
    • 15.8.1 PROGRESSIVE COMPANIES
    • 15.8.2 RESPONSIVE COMPANIES
    • 15.8.3 DYNAMIC COMPANIES
    • 15.8.4 STARTING BLOCKS
    • 15.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
      • 15.8.5.1 Detailed list of key startups/SMEs
      • 15.8.5.2 Competitive benchmarking of key startups/SMEs
  • 15.9 COMPETITIVE SCENARIO
    • 15.9.1 PRODUCT LAUNCHES
    • 15.9.2 DEALS
    • 15.9.3 EXPANSIONS

16 COMPANY PROFILES

  • 16.1 KEY PLAYERS
    • 16.1.1 GEA GROUP AKTIENGESELLSCHAFT
      • 16.1.1.1 Business overview
      • 16.1.1.2 Products/Solutions/Services offered
      • 16.1.1.3 Recent developments
        • 16.1.1.3.1 Product launches
        • 16.1.1.3.2 Deals
      • 16.1.1.4 MnM view
        • 16.1.1.4.1 Key strengths/Right to win
        • 16.1.1.4.2 Strategic choices
        • 16.1.1.4.3 Weaknesses/Competitive threats
    • 16.1.2 KORBER AG
      • 16.1.2.1 Business overview
      • 16.1.2.2 Products/Solutions/Services offered
      • 16.1.2.3 Recent developments
        • 16.1.2.3.1 Deals
        • 16.1.2.3.2 Expansions
      • 16.1.2.4 MnM view
        • 16.1.2.4.1 Key strengths/Right to win
        • 16.1.2.4.2 Strategic choices
        • 16.1.2.4.3 Weaknesses/Competitive threats
    • 16.1.3 IMA INDUSTRIA MACCHINE AUTOMATICHE SPA
      • 16.1.3.1 Business overview
      • 16.1.3.2 Products/Solutions/Services offered
      • 16.1.3.3 Recent developments
        • 16.1.3.3.1 Product launches
        • 16.1.3.3.2 Deals
      • 16.1.3.4 MnM view
        • 16.1.3.4.1 Key strengths/Right to win
        • 16.1.3.4.2 Strategic choices
        • 16.1.3.4.3 Weaknesses/Competitive threats
    • 16.1.4 SYNTEGON TECHNOLOGY GMBH
      • 16.1.4.1 Business overview
      • 16.1.4.2 Products/Solutions/Services offered
      • 16.1.4.3 Recent developments
        • 16.1.4.3.1 Product launches
        • 16.1.4.3.2 Deals
        • 16.1.4.3.3 Expansions
      • 16.1.4.4 MnM view
        • 16.1.4.4.1 Key strengths/Right to win
        • 16.1.4.4.2 Strategic choices
        • 16.1.4.4.3 Weaknesses/Competitive threats
    • 16.1.5 ACG
      • 16.1.5.1 Business overview
      • 16.1.5.2 Products/Solutions/Services offered
      • 16.1.5.3 Recent developments
        • 16.1.5.3.1 Deals
        • 16.1.5.3.2 Expansions
      • 16.1.5.4 MnM view
        • 16.1.5.4.1 Key strengths/Right to win
        • 16.1.5.4.2 Strategic choices
        • 16.1.5.4.3 Weaknesses/Competitive threats
    • 16.1.6 THERMO FISHER SCIENTIFIC INC.
      • 16.1.6.1 Business overview
      • 16.1.6.2 Products/Solutions/Services offered
      • 16.1.6.3 Recent developments
        • 16.1.6.3.1 Deals
        • 16.1.6.3.2 Expansions
    • 16.1.7 ROMACO GROUP
      • 16.1.7.1 Business overview
      • 16.1.7.2 Products/Solutions/Services offered
      • 16.1.7.3 Recent developments
        • 16.1.7.3.1 Product launches
        • 16.1.7.3.2 Deals
    • 16.1.8 MARCHESINI GROUP S.P.A.
      • 16.1.8.1 Business overview
      • 16.1.8.2 Products/Solutions/Services offered
      • 16.1.8.3 Recent developments
        • 16.1.8.3.1 Product launches
        • 16.1.8.3.2 Deals
    • 16.1.9 MG2 S.R.L.
      • 16.1.9.1 Business overview
      • 16.1.9.2 Products/Solutions/Services offered
      • 16.1.9.3 Recent developments
        • 16.1.9.3.1 Product launches
    • 16.1.10 GLATT GMBH
      • 16.1.10.1 Business overview
      • 16.1.10.2 Products/Solutions/Services offered
  • 16.2 OTHER PLAYERS
    • 16.2.1 BAUSCH+STROBEL SE + CO. KG
    • 16.2.2 COPERION GMBH
    • 16.2.3 ELIZABETH COMPANIES
    • 16.2.4 FETTE COMPACTING
    • 16.2.5 FREUND
    • 16.2.6 KORSCH AG
    • 16.2.7 L.B. BOHLE MASCHINEN UND VERFAHREN GMBH
    • 16.2.8 LFA MACHINES
    • 16.2.9 CVC TECHNOLOGIES, INC.
    • 16.2.10 OHARA TECHNOLOGIES
    • 16.2.11 PRISM PHARMA MACHINERY
    • 16.2.12 SAINTYCO
    • 16.2.13 SILVERSON
    • 16.2.14 YENCHEN MACHINERY CO., LTD.
    • 16.2.15 QUALICAPS
    • 16.2.16 COESIA S.P.A.
    • 16.2.17 UHLMANN
    • 16.2.18 AST, LLC

17 RESEARCH METHODOLOGY

  • 17.1 RESEARCH DATA
    • 17.1.1 SECONDARY AND PRIMARY RESEARCH
    • 17.1.2 SECONDARY DATA
      • 17.1.2.1 List of key secondary sources
      • 17.1.2.2 Key data from secondary sources
    • 17.1.3 PRIMARY DATA
      • 17.1.3.1 List of primary interview participants
      • 17.1.3.2 Key data from primary sources
      • 17.1.3.3 Key industry insights
      • 17.1.3.4 Breakdown of primaries
  • 17.2 MARKET SIZE ESTIMATION
    • 17.2.1 BOTTOM-UP APPROACH
    • 17.2.2 TOP-DOWN APPROACH
    • 17.2.3 MARKET SIZE CALCULATION FOR BASE YEAR
  • 17.3 MARKET FORECAST APPROACH
    • 17.3.1 SUPPLY SIDE
    • 17.3.2 DEMAND SIDE
  • 17.4 FACTOR ANALYSIS
  • 17.5 DATA TRIANGULATION
  • 17.6 RESEARCH ASSUMPTIONS
  • 17.7 RESEARCH LIMITATIONS
  • 17.8 RISK ANALYSIS

18 APPENDIX

  • 18.1 INSIGHTS FROM INDUSTRY EXPERTS
  • 18.2 DISCUSSION GUIDE
  • 18.3 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 18.4 CUSTOMIZATION OPTIONS
  • 18.5 RELATED REPORTS
  • 18.6 AUTHOR DETAILS

List of Tables

  • TABLE 1 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: INCLUSIONS AND EXCLUSIONS
  • TABLE 2 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: SUMMARY OF CHANGES
  • TABLE 3 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
  • TABLE 4 STRATEGIC FOCUS OF MAJOR COMPANIES IN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET
  • TABLE 5 IMPACT OF PORTER'S FIVE FORCES
  • TABLE 6 GDP GROWTH RATES, BY COUNTRY, 2021-2030 (%)
  • TABLE 7 ROLE OF COMPANIES IN PHARMACEUTICAL MANUFACTURING EQUIPMENT ECOSYSTEM
  • TABLE 8 PRICING RANGE OF PHARMACEUTICAL MANUFACTURING EQUIPMENT PROVIDED BY KEY PLAYERS, BY EQUIPMENT TYPE, 2025 (USD)
  • TABLE 9 AVERAGE SELLING PRICE TREND OF PACKAGING MACHINES, 2022-2025 (USD)
  • TABLE 10 AVERAGE SELLING PRICE TREND OF PACKAGING MACHINES, BY REGION, 2022-2025 (USD)
  • TABLE 11 IMPORT DATA FOR HS CODE 8479-COMPLIANT PRODUCTS, BY COUNTRY, 2021-2025 (USD MILLION)
  • TABLE 12 EXPORT DATA FOR HS CODE 8479-COMPLIANT PRODUCTS, BY COUNTRY, 2021-2025 (USD MILLION)
  • TABLE 13 LIST OF KEY CONFERENCES AND EVENTS, 2026
  • TABLE 14 INOXPA IMPLEMENTS MODULAR PHARMACEUTICAL PROCESSING SYSTEM TO STRENGTHEN AVVA PHARMACEUTICALS' MANUFACTURING CAPABILITIES
  • TABLE 15 GEA SUPPLIES PSD-3 PHARMACEUTICAL SPRAY DRYER TO HELP CHUGAI PHARMACEUTICAL PROCESS PHARMACEUTICAL COMPOUNDS
  • TABLE 16 ZAMBON COMPANY UNITES WITH IMA ACTIVE ON PROCESS OPTIMIZATION PROJECT TO SUPPORT PRODUCTION CAPACITY AND MAINTAIN OPERATIONAL EFFICIENCY
  • TABLE 17 ACG DEVELOPS RETROFIT SOLUTION TO INCREASE STABILITY AND SHELF LIFE OF INDIAN PHARMACEUTICAL COMPANY
  • TABLE 18 SYNTEGON'S AIM 5022S PLATFORM HELPS JIANGSU JINDIKE PHARMACEUTICAL ENHANCE INSPECTION EFFICIENCY AND ACCURACY OF PRE-FILLED SYRINGES
  • TABLE 19 US-ADJUSTED RECIPROCAL TARIFF RATES
  • TABLE 20 TECHNOLOGY ROADMAP IN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET
  • TABLE 21 LIST OF KEY PATENTS, 2023-2025
  • TABLE 22 TOP USE CASES AND MARKET POTENTIAL
  • TABLE 23 BEST PRACTICES FOLLOWED BY COMPANIES IN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET
  • TABLE 24 CASE STUDIES ON AI IMPLEMENTATION IN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET
  • TABLE 25 INTERCONNECTED ECOSYSTEM AND IMPACT ON PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET PLAYERS
  • TABLE 26 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 27 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 28 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 29 ROW: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 30 PHARMACEUTICAL MANUFACTURING EQUIPMENT INDUSTRY STANDARDS
  • TABLE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END-PRODUCT TYPE (%)
  • TABLE 32 KEY BUYING CRITERIA FOR END-PRODUCT TYPES
  • TABLE 33 UNMET NEEDS IN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE
  • TABLE 34 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2021-2025 (USD MILLION)
  • TABLE 35 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2026-2032 (USD MILLION)
  • TABLE 36 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2021-2025 (THOUSAND UNITS)
  • TABLE 37 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2026-2032 (THOUSAND UNITS)
  • TABLE 38 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2021-2025 (USD MILLION)
  • TABLE 39 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2026-2032 (USD MILLION)
  • TABLE 40 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2021-2025 (USD MILLION)
  • TABLE 41 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2026-2032 (USD MILLION)
  • TABLE 42 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2021-2025 (USD MILLION)
  • TABLE 43 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2026-2032 (USD MILLION)
  • TABLE 44 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2021-2025 (USD MILLION)
  • TABLE 45 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2026-2032 (USD MILLION)
  • TABLE 46 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2021-2025 (USD MILLION)
  • TABLE 47 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2026-2032 (USD MILLION)
  • TABLE 48 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2021-2025 (USD MILLION)
  • TABLE 49 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2026-2032 (USD MILLION)
  • TABLE 50 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2021-2025 (USD MILLION)
  • TABLE 51 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2026-2032 (USD MILLION)
  • TABLE 52 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2021-2025 (USD MILLION)
  • TABLE 53 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2026-2032 (USD MILLION)
  • TABLE 54 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2021-2025 (USD MILLION)
  • TABLE 55 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2026-2032 (USD MILLION)
  • TABLE 56 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2021-2025 (USD MILLION)
  • TABLE 57 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2026-2032 (USD MILLION)
  • TABLE 58 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2021-2025 (USD MILLION)
  • TABLE 59 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2026-2032 (USD MILLION)
  • TABLE 60 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2021-2025 (USD MILLION)
  • TABLE 61 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2026-2032 (USD MILLION)
  • TABLE 62 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2021-2025 (USD MILLION)
  • TABLE 63 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2026-2032 (USD MILLION)
  • TABLE 64 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2021-2025 (USD MILLION)
  • TABLE 65 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2026-2032 (USD MILLION)
  • TABLE 66 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2021-2025 (USD MILLION)
  • TABLE 67 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2026-2032 (USD MILLION)
  • TABLE 68 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2021-2025 (USD MILLION)
  • TABLE 69 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2026-2032 (USD MILLION)
  • TABLE 70 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2021-2025 (USD MILLION)
  • TABLE 71 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2026-2032 (USD MILLION)
  • TABLE 72 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2021-2025 (USD MILLION)
  • TABLE 73 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2026-2032 (USD MILLION)
  • TABLE 74 MIXING & BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2021-2025 (USD MILLION)
  • TABLE 75 MIXING & BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2026-2032 (USD MILLION)
  • TABLE 76 MIXING & BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2021-2025 (USD MILLION)
  • TABLE 77 MIXING & BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2026-2032 (USD MILLION)
  • TABLE 78 MIXING & BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2021-2025 (USD MILLION)
  • TABLE 79 MIXING & BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2026-2032 (USD MILLION)
  • TABLE 80 MIXING & BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2021-2025 (USD MILLION)
  • TABLE 81 MIXING & BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2026-2032 (USD MILLION)
  • TABLE 82 MIXING & BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2021-2025 (USD MILLION)
  • TABLE 83 MIXING & BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2026-2032 (USD MILLION)
  • TABLE 84 MIXING & BLENDING: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2021-2025 (USD MILLION)
  • TABLE 85 MIXING & BLENDING: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2026-2032 (USD MILLION)
  • TABLE 86 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2021-2025 (USD MILLION)
  • TABLE 87 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2026-2032 (USD MILLION)
  • TABLE 88 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2021-2025 (USD MILLION)
  • TABLE 89 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2026-2032 (USD MILLION)
  • TABLE 90 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2021-2025 (USD MILLION)
  • TABLE 91 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2026-2032 (USD MILLION)
  • TABLE 92 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2021-2025 (USD MILLION)
  • TABLE 93 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2026-2032 (USD MILLION)
  • TABLE 94 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2021-2025 (USD MILLION)
  • TABLE 95 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2026-2032 (USD MILLION)
  • TABLE 96 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2021-2025 (USD MILLION)
  • TABLE 97 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2026-2032 (USD MILLION)
  • TABLE 98 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2021-2025 (USD MILLION)
  • TABLE 99 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2026-2032 (USD MILLION)
  • TABLE 100 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2021-2025 (USD MILLION)
  • TABLE 101 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2026-2032 (USD MILLION)
  • TABLE 102 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2021-2025 (USD MILLION)
  • TABLE 103 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2026-2032 (USD MILLION)
  • TABLE 104 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2021-2025 (USD MILLION)
  • TABLE 105 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2026-2032 (USD MILLION)
  • TABLE 106 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2021-2025 (USD MILLION)
  • TABLE 107 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2026-2032 (USD MILLION)
  • TABLE 108 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2021-2025 (USD MILLION)
  • TABLE 109 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2026-2032 (USD MILLION)
  • TABLE 110 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2021-2025 (USD MILLION)
  • TABLE 111 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2026-2032 (USD MILLION)
  • TABLE 112 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2021-2025 (USD MILLION)
  • TABLE 113 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2026-2032 (USD MILLION)
  • TABLE 114 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2021-2025 (USD MILLION)
  • TABLE 115 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2026-2032 (USD MILLION)
  • TABLE 116 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2021-2025 (USD MILLION)
  • TABLE 117 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2026-2032 (USD MILLION)
  • TABLE 118 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2021-2025 (USD MILLION)
  • TABLE 119 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2026-2032 (USD MILLION)
  • TABLE 120 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2021-2025 (USD MILLION)
  • TABLE 121 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2026-2032 (USD MILLION)
  • TABLE 122 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2021-2025 (USD MILLION)
  • TABLE 123 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2026-2032 (USD MILLION)
  • TABLE 124 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2021-2025 (USD MILLION)
  • TABLE 125 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2026-2032 (USD MILLION)
  • TABLE 126 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2021-2025 (USD MILLION)
  • TABLE 127 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2026-2032 (USD MILLION)
  • TABLE 128 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2021-2025 (USD MILLION)
  • TABLE 129 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2026-2032 (USD MILLION)
  • TABLE 130 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2021-2025 (USD MILLION)
  • TABLE 131 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2026-2032 (USD MILLION)
  • TABLE 132 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2021-2025 (USD MILLION)
  • TABLE 133 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2026-2032 (USD MILLION)
  • TABLE 134 GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2021-2025 (USD MILLION)
  • TABLE 135 GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2026-2032 (USD MILLION)
  • TABLE 136 GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2021-2025 (USD MILLION)
  • TABLE 137 GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2026-2032 (USD MILLION)
  • TABLE 138 GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2021-2025 (USD MILLION)
  • TABLE 139 GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2026-2032 (USD MILLION)
  • TABLE 140 GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2021-2025 (USD MILLION)
  • TABLE 141 GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2026-2032 (USD MILLION)
  • TABLE 142 GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2021-2025 (USD MILLION)
  • TABLE 143 GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2026-2032 (USD MILLION)
  • TABLE 144 GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2021-2025 (USD MILLION)
  • TABLE 145 GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2026-2032 (USD MILLION)
  • TABLE 146 STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2021-2025 (USD MILLION)
  • TABLE 147 STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2026-2032 (USD MILLION)
  • TABLE 148 STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2021-2025 (USD MILLION)
  • TABLE 149 STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2026-2032 (USD MILLION)
  • TABLE 150 STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2021-2025 (USD MILLION)
  • TABLE 151 STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2026-2032 (USD MILLION)
  • TABLE 152 STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2021-2025 (USD MILLION)
  • TABLE 153 STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2026-2032 (USD MILLION)
  • TABLE 154 STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2021-2025 (USD MILLION)
  • TABLE 155 STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2026-2032 (USD MILLION)
  • TABLE 156 STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2021-2025 (USD MILLION)
  • TABLE 157 STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2026-2032 (USD MILLION)
  • TABLE 158 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2021-2025 (USD MILLION)
  • TABLE 159 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2026-2032, (USD MILLION)
  • TABLE 160 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY TECHNOLOGY, 2021-2025 (USD MILLION)
  • TABLE 161 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY TECHNOLOGY, 2026-2032, (USD MILLION)
  • TABLE 162 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2021-2025 (USD MILLION)
  • TABLE 163 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2026-2032 (USD MILLION)
  • TABLE 164 NORTH AMERICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY, 2021-2025 (USD MILLION)
  • TABLE 165 NORTH AMERICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY, 2026-2032 (USD MILLION)
  • TABLE 166 NORTH AMERICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2021-2025 (USD MILLION)
  • TABLE 167 NORTH AMERICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2026-2032 (USD MILLION)
  • TABLE 168 US: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2021-2025 (USD MILLION)
  • TABLE 169 US: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2026-2032 (USD MILLION)
  • TABLE 170 CANADA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2021-2025 (USD MILLION)
  • TABLE 171 CANADA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2026-2032 (USD MILLION)
  • TABLE 172 MEXICO: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2021-2025 (USD MILLION)
  • TABLE 173 MEXICO: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2026-2032 (USD MILLION)
  • TABLE 174 EUROPE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY, 2021-2025 (USD MILLION)
  • TABLE 175 EUROPE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY, 2026-2032 (USD MILLION)
  • TABLE 176 EUROPE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2021-2025 (USD MILLION)
  • TABLE 177 EUROPE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2026-2032 (USD MILLION)
  • TABLE 178 UK: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2021-2025 (USD MILLION)
  • TABLE 179 UK: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2026-2032 (USD MILLION)
  • TABLE 180 GERMANY: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2021-2025 (USD MILLION)
  • TABLE 181 GERMANY: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2026-2032 (USD MILLION)
  • TABLE 182 FRANCE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2021-2025 (USD MILLION)
  • TABLE 183 FRANCE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2026-2032 (USD MILLION)
  • TABLE 184 ITALY: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2021-2025 (USD MILLION)
  • TABLE 185 ITALY: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2026-2032 (USD MILLION)
  • TABLE 186 REST OF EUROPE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2021-2025 (USD MILLION)
  • TABLE 187 REST OF EUROPE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2026-2032 (USD MILLION)
  • TABLE 188 ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY, 2021-2025 (USD MILLION)
  • TABLE 189 ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY, 2026-2032 (USD MILLION)
  • TABLE 190 ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2021-2025 (USD MILLION)
  • TABLE 191 ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2026-2032 (USD MILLION)
  • TABLE 192 CHINA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2021-2025 (USD MILLION)
  • TABLE 193 CHINA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2026-2032 (USD MILLION)
  • TABLE 194 JAPAN: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2021-2025 (USD MILLION)
  • TABLE 195 JAPAN: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2026-2032 (USD MILLION)
  • TABLE 196 INDIA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2021-2025 (USD MILLION)
  • TABLE 197 INDIA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2026-2032 (USD MILLION)
  • TABLE 198 SOUTH KOREA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2021-2025 (USD MILLION)
  • TABLE 199 SOUTH KOREA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2026-2032 (USD MILLION)
  • TABLE 200 REST OF ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2021-2025 (USD MILLION)
  • TABLE 201 REST OF ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2026-2032 (USD MILLION)
  • TABLE 202 ROW: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2021-2025 (USD MILLION)
  • TABLE 203 ROW: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2026-2032 (USD MILLION)
  • TABLE 204 ROW: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2021-2025 (USD MILLION)
  • TABLE 205 ROW: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2026-2032 (USD MILLION)
  • TABLE 206 MIDDLE EAST & AFRICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY, 2021-2025 (USD MILLION)
  • TABLE 207 MIDDLE EAST & AFRICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY, 2026-2032 (USD MILLION)
  • TABLE 208 MIDDLE EAST & AFRICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2021-2025 (USD MILLION)
  • TABLE 209 MIDDLE EAST & AFRICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2026-2032 (USD MILLION)
  • TABLE 210 SOUTH AMERICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2021-2025 (USD MILLION)
  • TABLE 211 SOUTH AMERICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2026-2032 (USD MILLION)
  • TABLE 212 SOUTH AMERICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY, 2021-2025 (USD MILLION)
  • TABLE 213 SOUTH AMERICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY, 2026-2032 (USD MILLION)
  • TABLE 214 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS, JANUARY 2022-JANUARY 2026
  • TABLE 215 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: DEGREE OF COMPETITION, 2025
  • TABLE 216 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: REGION FOOTPRINT
  • TABLE 217 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: EQUIPMENT TYPE FOOTPRINT
  • TABLE 218 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: END-PRODUCT TYPE FOOTPRINT
  • TABLE 219 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: TECHNOLOGY FOOTPRINT
  • TABLE 220 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 221 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
  • TABLE 222 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: PRODUCT LAUNCHES, JANUARY 2022-JANUARY 2026
  • TABLE 223 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: DEALS, JANUARY 2022-JANUARY 2026
  • TABLE 224 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: EXPANSIONS, JANUARY 2022-JANUARY 2026
  • TABLE 225 GEA GROUP AKTIENGESELLSCHAFT: COMPANY OVERVIEW
  • TABLE 226 GEA GROUP AKTIENGESELLSCHAFT: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 227 GEA GROUP AKTIENGESELLSCHAFT: PRODUCT LAUNCHES
  • TABLE 228 GEA GROUP AKTIENGESELLSCHAFT: DEALS
  • TABLE 229 KORBER AG: COMPANY OVERVIEW
  • TABLE 230 KORBER AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 231 KORBER AG: DEALS
  • TABLE 232 KORBER AG: EXPANSIONS
  • TABLE 233 IMA INDUSTRIA MACCHINE AUTOMATICHE SPA: COMPANY OVERVIEW
  • TABLE 234 IMA INDUSTRIA MACCHINE AUTOMATICHE SPA: PRODUCTS/ SOLUTIONS/SERVICES OFFERED
  • TABLE 235 IMA INDUSTRIA MACCHINE AUTOMATICHE SPA: PRODUCT LAUNCHES
  • TABLE 236 IMA INDUSTRIA MACCHINE AUTOMATICHE SPA: DEALS
  • TABLE 237 SYNTEGON TECHNOLOGY GMBH: COMPANY OVERVIEW
  • TABLE 238 SYNTEGON TECHNOLOGY GMBH: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 239 SYNTEGON TECHNOLOGY GMBH: PRODUCT LAUNCHES
  • TABLE 240 SYNTEGON TECHNOLOGY GMBH: DEALS
  • TABLE 241 SYNTEGON TECHNOLOGY GMBH: EXPANSIONS
  • TABLE 242 ACG: COMPANY OVERVIEW
  • TABLE 243 ACG: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 244 ACG: DEALS
  • TABLE 245 ACG: EXPANSIONS
  • TABLE 246 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
  • TABLE 247 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 248 THERMO FISHER SCIENTIFIC INC.: DEALS
  • TABLE 249 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS
  • TABLE 250 ROMACO GROUP: COMPANY OVERVIEW
  • TABLE 251 ROMACO GROUP: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 252 ROMACO GROUP: PRODUCT LAUNCHES
  • TABLE 253 ROMACO GROUP: DEALS
  • TABLE 254 MARCHESINI GROUP S.P.A.: COMPANY OVERVIEW
  • TABLE 255 MARCHESINI GROUP S.P.A.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 256 MARCHESINI GROUP S.P.A.: PRODUCT LAUNCHES
  • TABLE 257 MARCHESINI GROUP S.P.A.: DEALS
  • TABLE 258 MG2 S.R.L.: COMPANY OVERVIEW
  • TABLE 259 MG2 S.R.L.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 260 MG2 S.R.L.: PRODUCT LAUNCHES
  • TABLE 261 GLATT GMBH: COMPANY OVERVIEW
  • TABLE 262 GLATT GMBH: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 263 BAUSCH+STROBEL SE + CO. KG: COMPANY OVERVIEW
  • TABLE 264 COPERION GMBH: COMPANY OVERVIEW
  • TABLE 265 ELIZABETH COMPANIES: COMPANY OVERVIEW
  • TABLE 266 FETTE COMPACTING: COMPANY OVERVIEW
  • TABLE 267 FREUND: COMPANY OVERVIEW
  • TABLE 268 KORSCH AG: COMPANY OVERVIEW
  • TABLE 269 L.B. BOHLE MASCHINEN UND VERFAHREN GMBH: COMPANY OVERVIEW
  • TABLE 270 LFA MACHINES: COMPANY OVERVIEW
  • TABLE 271 CVC TECHNOLOGIES, INC.: COMPANY OVERVIEW
  • TABLE 272 OHARA TECHNOLOGIES: COMPANY OVERVIEW
  • TABLE 273 PRISM PHARMA MACHINERY: COMPANY OVERVIEW
  • TABLE 274 SAINTYCO: COMPANY OVERVIEW
  • TABLE 275 SILVERSON: COMPANY OVERVIEW
  • TABLE 276 YENCHEN MACHINERY CO., LTD.: COMPANY OVERVIEW
  • TABLE 277 QUALICAPS: COMPANY OVERVIEW
  • TABLE 278 COESIA S.P.A.: COMPANY OVERVIEW
  • TABLE 279 UHLMANN: COMPANY OVERVIEW
  • TABLE 280 AST, LLC: COMPANY OVERVIEW
  • TABLE 281 MAJOR SECONDARY SOURCES
  • TABLE 282 PRIMARY INTERVIEW PARTICIPANTS
  • TABLE 283 DATA CAPTURED FROM PRIMARY SOURCES
  • TABLE 284 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: RISK ANALYSIS

List of Figures

  • FIGURE 1 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SEGMENTATION AND REGIONAL SCOPE
  • FIGURE 2 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: DURATION COVERED
  • FIGURE 3 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SCENARIO
  • FIGURE 4 GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, 2021-2032
  • FIGURE 5 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, JANUARY 2022-JANUARY 2026
  • FIGURE 6 DISRUPTIONS INFLUENCING GROWTH OF PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET
  • FIGURE 7 HIGH-GROWTH SEGMENTS IN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, 2026-2032
  • FIGURE 8 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET DURING FORECAST PERIOD
  • FIGURE 9 HIGH EMPHASIS ON AUTOMATING PRODUCTION AND IMPROVING THROUGHPUT TO DRIVE PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET
  • FIGURE 10 PACKAGING MACHINES SEGMENT TO CAPTURE LARGEST MARKET SHARE IN 2026 AND 2032
  • FIGURE 11 LIQUID SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE IN 2032
  • FIGURE 12 AUTOMATIC TECHNOLOGY TO DOMINATE MARKET SHARE FROM 2026 TO 2032
  • FIGURE 13 PACKAGING MACHINES SEGMENT AND US TO HOLD LARGEST SHARE OF PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA IN 2032
  • FIGURE 14 INDIA TO BE FASTEST-GROWING MARKET FOR PHARMACEUTICAL MANUFACTURING EQUIPMENT DURING FORECAST PERIOD
  • FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 16 IMPACT ANALYSIS: DRIVERS
  • FIGURE 17 IMPACT ANALYSIS: RESTRAINTS
  • FIGURE 18 IMPACT ANALYSIS: OPPORTUNITIES
  • FIGURE 19 IMPACT ANALYSIS: CHALLENGES
  • FIGURE 20 PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 21 PHARMACEUTICAL MANUFACTURING EQUIPMENT VALUE CHAIN ANALYSIS
  • FIGURE 22 PHARMACEUTICAL MANUFACTURING EQUIPMENT ECOSYSTEM
  • FIGURE 23 AVERAGE SELLING PRICE TREND OF PHARMACEUTICAL PACKAGING MACHINES, 2022-2025
  • FIGURE 24 AVERAGE SELLING PRICE TREND OF PHARMACEUTICAL PACKAGING MACHINES, BY REGION, 2022-2025
  • FIGURE 25 INVESTMENT AND FUNDING SCENARIO, 2020-2024
  • FIGURE 26 IMPORT SCENARIO FOR HS CODE 8479-COMPLIANT PRODUCTS IN TOP FIVE COUNTRIES, 2021-2025
  • FIGURE 27 EXPORT SCENARIO FOR HS CODE 8479-COMPLIANT PRODUCTS IN TOP FIVE COUNTRIES, 2021-2025
  • FIGURE 28 TRENDS/DISRUPTIONS INFLUENCING CUSTOMER BUSINESS
  • FIGURE 29 PATENT APPLIED AND GRANTED, 2016-2025
  • FIGURE 30 DECISION-MAKING FACTORS CONSIDERED WHILE BUYING PHARMACEUTICAL MANUFACTURING EQUIPMENT
  • FIGURE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END-PRODUCT TYPE
  • FIGURE 32 KEY BUYING CRITERIA, BY END-PRODUCT TYPE
  • FIGURE 33 PHARMACEUTICAL MANUFACTURING EQUIPMENT ADOPTION BARRIERS AND INTERNAL CHALLENGES
  • FIGURE 34 PHARMACEUTICAL MANUFACTURING EQUIPMENT END USERS
  • FIGURE 35 MAJOR PHARMACEUTICAL EQUIPMENT MANUFACTURING PROCESSES
  • FIGURE 36 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE
  • FIGURE 37 PACKAGING MACHINES SEGMENT TO DOMINATE MARKET FROM 2026 TO 2032
  • FIGURE 38 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE
  • FIGURE 39 SOLID SEGMENT TO ACCOUNT FOR LARGER SHARE OF PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN 2026
  • FIGURE 40 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY TECHNOLOGY
  • FIGURE 41 AUTOMATIC SEGMENT TO CAPTURE LARGEST SHARE OF PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN 2026
  • FIGURE 42 ASIA PACIFIC TO EXHIBIT HIGHEST CAGR BETWEEN 2026 AND 2032
  • FIGURE 43 NORTH AMERICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SNAPSHOT
  • FIGURE 44 EUROPE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SNAPSHOT
  • FIGURE 45 ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SNAPSHOT
  • FIGURE 46 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: REVENUE ANALYSIS OF TOP PLAYER, 2020-2024
  • FIGURE 47 MARKET SHARE ANALYSIS OF COMPANIES OFFERING PHARMACEUTICAL MANUFACTURING EQUIPMENT, 2025
  • FIGURE 48 COMPANY VALUATION
  • FIGURE 49 FINANCIAL METRICS (EV/EBITDA)
  • FIGURE 50 BRAND COMPARISON
  • FIGURE 51 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: COMPANY EVALUATION MATRIX (KEY COMPANIES), 2025
  • FIGURE 52 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: COMPANY FOOTPRINT
  • FIGURE 53 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
  • FIGURE 54 GEA GROUP AKTIENGESELLSCHAFT: COMPANY SNAPSHOT
  • FIGURE 55 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
  • FIGURE 56 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: RESEARCH DESIGN
  • FIGURE 57 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: RESEARCH APPROACH
  • FIGURE 58 DATA CAPTURED FROM SECONDARY SOURCES
  • FIGURE 59 CORE FINDINGS FROM INDUSTRY EXPERTS
  • FIGURE 60 BREAKDOWN OF PRIMARY INTERVIEW, BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 61 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: BOTTOM-UP APPROACH
  • FIGURE 62 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: TOP-DOWN APPROACH
  • FIGURE 63 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE ESTIMATION (SUPPLY SIDE)
  • FIGURE 64 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: FACTOR ANALYSIS
  • FIGURE 65 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: DATA TRIANGULATION
  • FIGURE 66 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: RESEARCH ASSUMPTIONS
  • FIGURE 67 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: INSIGHTS FROM INDUSTRY EXPERTS